Sign in with your email address username.


[Department of Error] Department of Error

Verheugt FWA, Granger CB. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. Lancet 2015; 386: 303–10—In table 1 of this Series paper, the drug metabolism row for the RE-LY trial should have stated only P-glycoprotein. This correction has been made to the printed paper, and to the online version as of July 17, 2015.